PKU Healthcare
| Formerly | Southwest Pharmaceutical | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Company type | public | ||||||||||||||
| Industry | pharmaceutical | ||||||||||||||
| Owner |
| ||||||||||||||
| Parent |
| ||||||||||||||
| Website | pku-hc.com |
PKU Healthcare Corp., Ltd. formerly known as PKU International Healthcare Group Southwest Pharmaceutical Co., Ltd., is a Chinese pharmaceutical company. The major shareholder was PKU Healthcare Group, a subsidiary of PKU Founder Group. PKU Founder Group itself is a subsidiary of Peking University.
History
PKU International Healthcare Group Southwest Pharmaceutical Co., Ltd. (Chinese: 北大国际医院集团西南合成制药股份有限公司)
Shareholders
As at 31 December 2015, PKU Healthcare Group owned 40.74% shares of PKU Healthcare directly and indirectly (via Southwest Pharmaceutical Group) as the largest shareholder; PKU Founder Group was the parent company of PKU Healthcare Group for 85.60%, with the rest were owned by Peking University ; Peking University's wholly owned subsidiary: Peking University Asset Management owned 70% stake of PKU Founder Group; as Peking University was supervised by the Ministry of Education, PKU Healthcare was considered a state-owned enterprise in board definition.[1]
The second largest shareholder was China Securities Finance for 1.94% shares.
References
- ^ "2015 Annual Report" (PDF). PKU Healthcare (in Chinese). Shenzhen Stock Exchange. 29 April 2016. Retrieved 28 February 2017.